Yanda International Hospital
Parkinson's disease treatment cost in China typically involves diagnostic imaging like brain MRI with contrast, which runs $300 to $600. Primary surgical interventions such as deep brain stimulation (DBS) surgery range from $34,500 to $59,000, while stem cell therapy for Parkinson's disease costs $22,500 to $59,000. Total expenses depend on disease severity, medical protocols, and facility tier. Patients often save 40-70% compared to US prices. Top destinations include Beijing and Tianjin.
Typical Parkinson's Disease Treatment Costs in China
Bookimed Expert Insight: Patients seeking high-level care benefit from Class A level III facilities like Yanda International Hospital. This JCI-accredited center offers integrated international protocols and traditional Chinese approaches for over 2.5 million annual patients. For specialized neuromodulation, Dr. Eber Brain Hospital in Tianjin features tertiary-level care for motor function restoration. Complex cases are best managed by experts like Shao Ming, who trained at Harvard and Texas University.
| China | Turkey | Austria | |
| Medication treatment for Parkinson's disease | from $3,800 | from $1,000 | from $2,000 |
| Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) | from $15,500 | from $10,000 | from $16,000 |
| Deep brain stimulation (DBS) surgery | from $34,500 | from $23,000 | from $45,000 |
| Stem cell therapy for Parkinson's disease | from $22,500 | from $25,000 | from $35,000 |
| Induced Pluripotent Stem Cells Therapy | from $32,000 | - | - |
Professor Sun Chen Yang is a leading physician and doctor-scientist of ancient Chinese medicine Qihuang, specializing in Parkinson's disease at Tianjin Eber Perennial Brain Hospital.
32 years of experience of neurology experience – Dr. Shao Ming specializes in movement disorders like Parkinson's at Tianjin Eber Perennial Brain Hospital.
Professor ZHENG Wei Hong is Director of the Department of Neurology and the discipline leader. He previously served as Director of Neurology at Xiamen University Affiliated Zhongshan Hospital. He is a Professor at Xiamen University and a master's supervisor.
His clinical focus includes etiological investigation, prevention, and treatment of cerebral infarction and cerebral hemorrhage. He also diagnoses and treats complex neurological diseases, including epilepsy, neuroimmunological and neuromuscular disorders (myasthenia gravis, multiple sclerosis), and Parkinson's disease.
Appointments: He serves as a committee member of the Neuroimmunology Group (Chinese Medical Association Neurology Branch), the Immunology Branch (Chinese Stroke Association), Neurorestoration (Chinese Medical Doctor Association), and Cognitive Impairment (Chinese Geriatrics Society). He is on the Standing Committee of the Expert Committee of Stroke Screening and Prevention Engineering Base Hospitals (Ministry of Health). He is a member of the Neurology Expert Group, Fujian Provincial Medical Quality Control Center for Stroke and Epilepsy. He is Standing Director of the Fujian Anti‑Epilepsy Association. He is Deputy Group Leader of the Epilepsy and Electroencephalography Group (Fujian Medical Association Neurology Branch). He is Deputy Chairperson of the 1st Committee, Neurology Physicians Branch (Fujian Medical Doctor Association). He is a Standing Committee Member (5th–7th) of the Neurology Branch (Fujian Medical Association). He is Deputy Chairperson of the Neurology Professional Committee (Xiamen Medical Association).
Written by Kateryna Zamkovska
Primary Parkinson's treatment in China integrates Western pharmacological standards, advanced neurosurgery, and Traditional Chinese Medicine (TCM). Specialized centers offer Deep Brain Stimulation (DBS) and Magnetic Resonance-guided Focused Ultrasound (MRgFUS). Some institutions also conduct research into induced pluripotent stem cell therapies for neurorestoration.
Bookimed Expert Insight: China's Class A Level III hospitals, like Yanda International, offer a rare structural advantage by combining JCI-accredited neurology departments with ancient Qihuang medicinal research. This allows patients to access high-tech interventions like DBS alongside highly regulated TCM protocols. While general clinics exist, choosing facilities with academic ties to institutions like Peking University ensures a higher standard of supervised, multi-modal care.
Patient Consensus: Patients note that standard medications and DBS are widely accessible and affordable. Many advise caution regarding unproven stem cell `cures,` recommending that newcomers stick to established hospitals and verify treatment claims through long-term tracking.
Stem cell therapy for Parkinson disease in China remains experimental. Clinical trials show up to 80% efficiency in converting stem cells into functional dopamine neurons. Most advanced neural transplants are restricted to competitive trials in Beijing and Shanghai. They are not yet standard treatments.
Bookimed Expert Insight: While experimental stem cell research dominates headlines, established facilities like Yanda International Hospital serve 2,500,000 patients annually using JCI-accredited protocols. Our data shows that top Chinese neurosurgeons, such as Dr. Shao Ming, often hold multiple fellowships from Harvard or UCLA. Patients seeking movement disorder treatments should prioritize these high-volume, accredited hospitals over smaller, unproven clinics offering experimental injections.
Patient Consensus: Patients note that while medical visas for China are accessible, many stem cell treatments currently offered through tourism are considered unproven. International communities strongly recommend choosing established therapies like Deep Brain Stimulation or waiting for peer-reviewed Phase III trial results.
China integrates traditional Chinese medicine with modern neurosurgery and cell-based therapies. Treatment often begins at earlier disease stages compared to Western protocols. High-volume centers perform deep brain stimulation and magnetic resonance-guided focused ultrasound surgery. This proactive approach aims to balance body systems while managing motor symptoms.
Bookimed Expert Insight: Clinical data from Yanda International Hospital shows how China manages massive patient volumes. This Joint Commission International-accredited facility serves 2,500,000 patients annually. Such high volume allows Chinese specialists to gain surgical experience much faster than Western peers. For example, Dr. Zheng Wei Hong manages complex movement disorders within a system performing 9,000 operations yearly. This experience often leads to shorter wait times for advanced procedures like stereotactic electrode implantation.
Patient Consensus: Patients often notice that Chinese clinics offer intensive cell-based therapies and focused ultrasound much sooner than Western doctors. They highlight the importance of choosing high-volume, accredited hospitals to ensure safety and better follow-up care.
Tai Chi measurably slows Parkinson's progression by improving motor and non-motor functions. Clinical research confirms it reduces medication dependency and enhances brain connectivity. Regular practice specifically targets balance and gait. It performs better than standard stretching in preventing falls and decreasing neuroinflammation.
Bookimed Expert Insight: The most effective results come from combining traditional movement with advanced diagnostics. Centers like Yanda International Hospital hold Joint Commission International accreditation and use over 28,000 modern technologies. Patients benefit when specialists like Dr. Sun Chen Yang integrate ancient Qihuang medicine with Western protocols. This dual approach ensures that while Tai Chi manages symptoms, professional neurosurgical expertise addresses underlying structural issues.
Patient Consensus: Patients note that Tai Chi significantly improves stability and reduces the fear of falling. While it complements medication, they emphasize that results only appear with consistent practice at least twice weekly.
Traditional Chinese Medicine (TCM) serves as a holistic, complementary therapy for Parkinson's disease in China. Specialized clinics integrate acupuncture and herbal formulas with conventional treatments like Deep Brain Stimulation (DBS). This combined approach aims to alleviate motor symptoms, reduce medication side effects, and improve long-term sleep quality.
Bookimed Expert Insight: Bookimed data shows that leading Chinese institutions, such as Yanda International Hospital, operate at a Class A Level III status. This is the highest medical tier in China. These centers treat over 2,500,000 patients annually and emphasize multidisciplinary care. For Parkinson's, this means patients often receive care from teams led by both neurosurgeons and TCM professors. For example, Dr. Sun Chen Yang is a professor of integrative medicine and a recognized specialist in ancient Qihuang medicine. This level of integration ensures that traditional therapies like acupuncture are clinically supervised by neurological experts to maximize safety and efficacy.
Patient Consensus: Patients note that starting with acupuncture can be a low-risk way to address tremors. Many emphasize that while herbs may help reduce side effects like dyskinesia by 30% to 50%, it is crucial to monitor bloodwork with a neurologist to prevent drug interactions.
International patients can access stem cell therapy, deep brain stimulation, and MRgFUS for Parkinson's disease in China. Specialized institutions like Dr. Eber Brain Hospital and JCI-accredited Yanda International Hospital provide these advanced neurological treatments. Access typically requires an official invitation letter for medical visa support.
Bookimed Expert Insight: While many patients focus on stem cells, Bookimed data shows high demand for structured surgical interventions. A DBS procedure at Xiamen Humanity Hospital costs approximately $41,400 (300,000 CNY). This price includes 15 days of inpatient monitoring. This reflects a trend where Chinese tertiary centers bundle extended rehabilitation with high-tech surgery. It offers more comprehensive post-op care than standard outpatient models found in other regions.
Patient Consensus: Patients often find that while initial motor symptom relief is significant, long-term results vary. Many emphasize the need to arrange independent translation services as English post-operative support can be limited.
Deep Brain Stimulation (DBS) is widely available in China at major neurological centres. Leading surgeons are highly experienced. Some specialists have performed over 10,000 surgical localisation procedures. Facilities in Beijing, Shanghai, and Tianjin use robotic navigation and closed-loop technologies for Parkinson's treatment.
Bookimed Expert Insight: China has over 100 hospitals offering DBS, but volume varies between centres. Major institutions like Yanda International Hospital serve up to 2,500,000 patients annually. Choosing a high-volume hub is vital. Specialists like Dr Shao Ming at Dr Eber Brain Hospital bring international experience from Harvard and the University of Texas.
Patient Consensus: Patients highlight that successful DBS outcomes depend on the specific centre case volume. They emphasise confirming long-term follow-up plans. They also recommend checking for English language support for post-operative device adjustments.
Stem cell therapies for Parkinson's disease in China are experimental rather than standard clinical practice. While state-approved trials exist, they are not validated for routine use. Patients must distinguish between regulated clinical research and unproven commercial packages. Verified facilities often hold international JCI accreditation.
Bookimed Expert Insight: While commercial stem cell packages exist, top specialists in China focus on functional neurosurgery. For instance, Dr Li Yanwen has performed over 10,000 surgical localisations. This volume of surgical experience often provides more predictable outcomes than experimental cell therapies.
Patient Consensus: Patients in China suggest treating stem cell offers as research rather than cures. They advise getting an independent specialist's opinion. It is vital to verify if a trial has ethics approval or is a pay-to-participate model.
China reports a 55.5% success rate for new non-invasive brain circuit stimulation targeting the SCAN area. Precision millimetre-level systems deliver outcomes twice as effective as traditional methods. Major clinics like Yanda International Hospital hold JCI accreditation. This maintains high standards for Australian patients.
Bookimed Expert Insight: Success in China often involves a hybrid approach. Yanda International Hospital combines international protocols with traditional Chinese medicine. They serve 2,500,000 patients annually. For Parkinson's, combining neuro-navigation with integrated therapy helps maintain long-term mobility better than single-method treatments.
Patient Consensus: Patients define success by improved mobility and reduced tremors rather than a total cure. They emphasise confirming if treatments are standard or experimental. They also recommend arranging follow-up plans before returning to Australia.
Integrating Traditional Chinese Medicine with Western treatments for Parkinson's is standard practice in China. This approach combines neurological drugs like Levodopa with acupuncture and herbal therapies. It aims to reduce medication side effects and improve motor function.
Bookimed Expert Insight: Many patients seek Traditional Chinese Medicine first. However, the most effective integrative care happens in large hospitals. JCI-accredited facilities like Yanda International Hospital serve millions of patients. These centres monitor herbal therapies to prevent interference with Western drugs. Doctors there, such as Dr Shao Ming, often have postdoctoral training at Harvard. This helps maintains Western standards while adding traditional supportive therapies correctly.
Patient Consensus: Patients emphasise using traditional medicine alongside standard Western drugs, not as a replacement. Those who choose hospital-based settings in China report the best balance of symptom relief and safety.
Top hospitals for Parkinson's treatment in China include Yanda International Hospital and Dr. Eber Brain Hospital. These JCI-accredited tertiary centres specialise in neurosurgery. They offer deep brain stimulation (DBS) and stereotactic electrode implantation to manage movement disorders and neurological symptoms.
Bookimed Expert Insight: Parkinson's care in China often combines neurosurgery with large-scale diagnostics. Xiamen Humanity Hospital offers 15-day recovery packages for A$57,000. Yanda International serves 2,500,000 patients annually. This massive scale helps surgeons develop deep expertise across thousands of cases every year.
Patient Consensus: Patients suggest choosing major tertiary centres in large cities. They should also confirm the doctor's specific movement disorder subspecialty. It is helpful to check for English-language support and discuss long-term follow-up before travelling.